PDND
Phytochemical Database for Neurological Disorders
search icon
Advanced search

Phytochemical Name : Apomorphine
PCNDIDA0159
Pubchem CID : 6005
Molecular formula: C17H17NO2

Molecular weight : 267.320

Canonical SMILES : CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O

Synonymes : apomorphine|L-Apomorphine|58-00-4|Apomorphin|Apomorfin|Apokyn|R-(-)-Apomorphine|Ixense|Uprima|Apomorphine hydrochloride|(R)-(-)-Apomorphine|(-)-Apomorphine|(-)-10,11-Dihydroxyaporphine|Apomorphinum|6abeta-Aporphine-10,11-diol|VR-040|Apomorphine [BAN]|Apomorphine free base|Apomorphine HCl|6a-beta-Aporphine-10,11-diol|C17H17NO2|HSDB 3289|(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphine hydrochloride hemihydrate|CHEMBL53|EINECS 200-360-0|UNII-N21FAR7B4S|APL-130277|N21FAR7B4S|Apormorphine|(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol|58-00-4 (free base)|DTXSID8022614|CHEBI:48538|6a.beta.-aporphine-10,11-diol|VR040|Apomorphine (BAN)|4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-|Apomorphinium chloride hemihydrate|NCGC00025349-02|Uprima (TN)|DTXCID302614|41372-20-7|(R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphine hydrochloride hydrate|CAS-58-00-4|(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol|apomorphin-|IV Apomorphine|(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|(6AR)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO(DE,G)QUINOLINE-10,11-DIOL|4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-|VR004|VR-400|Apomorphine (R,-)|C17H17NO2.ClH.1/2H2O|Tocris-2073|APOMORPHINE [MI]|Prestwick0_000101|Prestwick1_000101|Prestwick2_000101|Prestwick3_000101|Kynmobi (sublingual film)|APOMORPHINE [HSDB]|Biomol-NT_000019|D0H6QU|GTPL33|APOMORPHINE [VANDF]|APOMORPHINUM [HPUS]|SCHEMBL8541|C17-H17-N-O2.Cl-H.1/2H2-O|APOMORPHINE [WHO-DD]|BSPBio_000082|SPBio_002021|BPBio1_000092|BPBio1_001179|BDBM29644|cid_6852399|HMS2089C10|NH001|Tox21_110967|BDBM50001955|PDSP1_000780|PDSP2_001488|AKOS040740360|Tox21_110967_1|DB00714|SMP1_000027|NCGC00025349-01|NCGC00025349-03|NCGC00025349-04|NCGC00025349-05|LS-21474|Apomorphine (intranasal, Parkinson's disease)|D07460|EN300-18161186|Q269111|Q-200645|BRD-K76022557-001-01-3|BRD-K76022557-311-20-6|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|(-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO)|(Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|(apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|(R)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO[DE-G]QUINOLINE-10,11-DIOL|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine)|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine)|6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)|6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine)|APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride|(9R)-10-methyl-10-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,13(17),14-hexaene-3,4-diol|(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol|OR9

Structure
3D structure 2D structure
6005
Predicted properties (NCBI Pubchem)

Physicochemical Properties